Revolution Medicines's banner
Revolution Medicines's profile picture

Revolution Medicines

@RevMedicines • 1,554 subscribers

We aim to change the trajectory of disease for patients living with RAS-addicted cancers around the world. Community guidelines: https://t.co/pWFE3dt54s

Shorts

The U.S. FDA approved the first multi‑selective oral RAS inhibitor in metastatic pancreatic cancer. More:

The U.S. FDA approved the first multi‑selective oral RAS inhibitor in metastatic pancreatic cancer. More:

22,571 views